Barclays Maintains Underweight on XPeng, Lowers Price Target to $14

Benzinga Newsdesk www.benzinga.com Negative 84.0%

Neg 84% Neu 0% Pos 0%

Barclays analyst Jiong Shao maintains XPeng (NYSE:XPEV) with a Underweight and lowers the price target from $15 to $14.

Comments

No comments yet. Be the first!